Korean firm to sell ED drug in Mid East
October 27, 2006

SEOUL, Oct. 27 (UPI) -- Korean firm Dong-A Pharmaceutical said Friday it has granted Saudi firm SCP the rights to sell its erectile dysfunction drug in the Middle East.

Dong-A said SCP will distribute its ED drug Zydena in the Gulf Cooperation Council countries, including Saudi Arabia, Oman, Bahrain, Kuwait, UAE and Qatar.

The pact with SCP positions Zydena to compete with other ED therapies already sold in the Middle East, including Pfizer's Viagra, Lilly's Cialis and Bayer's Levitra, Dong-A said.
While the drug has not yet been approved in the United States, Zydena was launched in Korea in December 2005 and has exceeded more than 20 percent (by volume) of the Korean market, the company noted.

The drug's name should help with brand recognition in the Gulf states, the Korean firm said, noting that the Arabic pronunciation of Zydena translates to "give me more."

Source: http://www.upi.com/HealthBusiness/view.php?StoryID=20061027-022938-5924r